Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability

FASEB Journal

Volumn 27, Issue 7, 2013, Pages 2880-2892

  Lyssenko, Nicholas N ^a   Nickel, Margaret ^a   Tang, Chongren ^b   Phillips, Michael C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Discoidal HDL; HDL quality; Macrophage reverse cholesterol transport; Reconstituted HDL

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ARTICLE; BIOGENESIS; CELL DENSITY; CHOLESTEROL TRANSPORT; GAS LIQUID CHROMATOGRAPHY; GEL FILTRATION CHROMATOGRAPHY; MACROPHAGE; MOLECULE; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; WILD TYPE;

DISCOIDAL HDL; HDL QUALITY; MACROPHAGE REVERSE CHOLESTEROL TRANSPORT; RECONSTITUTED HDL;

ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; CELL COUNT; CELL LINE; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEP G2 CELLS; HUMANS; KINETICS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, HDL; MACROPHAGES; MIFEPRISTONE; MUTATION; PARTICLE SIZE;

EID: 84879669028     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-216564     Document Type: Article

References (67)

1. Rothblat, G. H., and Phillips, M. C. (2010) High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr. Opin. Lipidol. 21, 229-238
2. Rosenson, R. S., Brewer, H. B., Jr., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., and Schaefer, E. J. (2011) HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin. Chem. 57, 392-410
3. Scanu, A. M., Byrne, R. E., and Mihovilovic, M. (1982) Functional roles of plasma high density lipoproteins. CRC Crit. Rev. Biochem. 13, 109-140
4. Glomset, J. A. (1970) Physiological role of lecithin-cholesterol acyltransferase. Am. J. Clin. Nutr. 23, 1129-1136
5. Miller, G. J. (1980) High density lipoproteins and atherosclerosis. Annu. Rev. Med. 31, 97-108
6. Negi, S., and Ballantyne, C. M. (2010) Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression. J. Clin. Lipidol. 4, 365-370
7. Lewis, G. F., and Rader, D. J. (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232 (Pubitemid 40962099)
8. Besler, C., Lüscher, T. F., and Landmesser, U. (2012) Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease. EMBO Mol. Med. 4, 251-268
9. Rader, D. J., and Tall, A. R. (2012) The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat. Med. 18, 1344-1346
10. Eisenberg, S. (1984) High density lipoprotein metabolism. J. Lipid Res. 25, 1017-1058
11. Assmann, G., Herbert, P. N., Fredrickson, D. S., and Forte, T. (1977) Isolation and characterization of an abnormal high density lipoprotein in Tangier disease. J. Clin. Invest. 60, 242-252 (Pubitemid 8145162)
12. Timmins, J. M., Lee, J. Y., Boudyguina, E., Kluckman, K. D., Brunham, L. R., Mulya, A., Gebre, A. K., Coutinho, J. M., Colvin, P. L., Smith, T. L., Hayden, M. R., Maeda, N., and Parks, J. S. (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115, 1333-1342 (Pubitemid 40629053)
13. Brunham, L. R., Kruit, J. K., Iqbal, J., Fievet, C., Timmins, J. M., Pape, T. D., Coburn, B. A., Bissada, N., Staels, B., Groen, A. K., Hussain, M. M., Parks, J. S., Kuipers, F., and Hayden, M. R. (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116, 1052-1062
14. Miller, J. C., Barth, R. K., Shaw, P. H., Elliott, R. W., and Hastie, N. D. (1983) Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine. Proc. Natl. Acad. Sci. U. S. A. 80, 1511-1515 (Pubitemid 13052440)
15. Haghpassand, M., Bourassa, P. A., Francone, O. L., and Aiello, R. J. (2001) Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108, 1315-1320 (Pubitemid 33107759)
16. Chisholm, J. W., Burleson, E. R., Shelness, G. S., and Parks, J. S. (2002) ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J. Lipid Res. 43, 36-44 (Pubitemid 34117215)
17. Kiss, R. S., McManus, D. C., Franklin, V., Tan, W. L., McKenzie, A., Chimini, G., and Marcel, Y. L. (2003) The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J. Biol. Chem. 278, 10119-10127 (Pubitemid 36800269)
18. Denis, M., Landry, Y. D., and Zha, X. (2008) ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments. J. Biol. Chem. 283, 16178-16186
19. Faulkner, L. E., Panagotopulos, S. E., Johnson, J. D., Woollett, L. A., Hui, D. Y., Witting, S. R., Maiorano, J. N., and Davidson, W. S. (2008) An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages. J. Lipid Res. 49, 1322-1332
20. Verghese, P. B., Arrese, E. L., Howard, A. D., and Soulages, J. L. (2008) Brefeldin A inhibits cholesterol efflux without affecting the rate of cellular uptake and re-secretion of apolipoprotein A-I in adipocytes. Arch. Biochem. Biophys. 478, 161-166
21. Camont, L., Chapman, M. J., and Kontush, A. (2011) Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol. Med. 17, 594-603
22. De la Llera-Moya, M., Drazul-Schrader, D., Asztalos, B. F., Cuchel, M., Rader, D. J., and Rothblat, G. H. (2010) The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler. Thromb. Vasc. Biol. 30, 796-801
23. Sorci-Thomas, M. G., Owen, J. S., Fulp, B., Bhat, S., Zhu, X., Parks, J. S., Shah, D., Jerome, W. G., Gerelus, M., Zabalawi, M., and Thomas, M. J. (2012) Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J. Lipid Res. 53, 1890-1909
24. Duong, P. T., Collins, H. L., Nickel, M., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (2006) Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I. J. Lipid Res. 47, 832-843
25. Krimbou, L., Hajj Hassan, H., Blain, S., Rashid, S., Denis, M., Marcil, M., and Genest, J. (2005) Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines. J. Lipid Res. 46, 1668-1677 (Pubitemid 41099334)
26. Hayashi, M., Abe-Dohmae, S., Okazaki, M., Ueda, K., and Yokoyama, S. (2005) Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J. Lipid Res. 46, 1703-1711 (Pubitemid 41099337)
27. Liu, L., Bortnick, A. E., Nickel, M., Dhanasekaran, P., Subbaiah, P. V., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (2003) Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278, 42976-42984 (Pubitemid 37345910)
28. Forte, T. M., Goth-Goldstein, R., Nordhausen, R. W., and McCall, M. R. (1993) Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J. Lipid Res. 34, 317-324 (Pubitemid 23067536)
29. Ritter, M. C., and Scanu, A. M. (1977) Role of apolipoprotein A-I in the structure of human serum high density lipoproteins: reconstitution studies. J. Biol. Chem. 252, 1208-1216 (Pubitemid 8047876)
30. Swaney, J. B. (1980) Properties of lipid • apolipoprotein association products: complexes of dimyristoyl phosphatidylcholine and human apo A-1. J. Biol. Chem. 255, 877-881
31. Matz, C. E., and Jonas, A. (1982) Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535-4540
32. Lund-Katz, S., and Phillips, M. C. (2010) High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 51, 183-227
33. Jonas, A. (1986) Reconstitution of high-density lipoproteins. Methods Enzymol. 128, 553-582
34. Vedhachalam, C., Duong, P. T., Nickel, M., Nguyen, D., Dhanasekaran, P., Saito, H., Rothblat, G. H., Lund-Katz, S., and Phillips, M. C. (2007) Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J. Biol. Chem. 282, 25123-25130 (Pubitemid 47347535)
35. Lyssenko, N. N., Brubaker, G., Smith, B. D., and Smith, J. D. (2011) A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells. Arterioscler. Thromb. Vasc. Biol. 31, 2700-2706
36. Oram, J. F., Vaughan, A. M., and Stocker, R. (2001) ATPbinding cassette transporter A1 mediates cellular secretion of α-tocopherol. J. Biol. Chem. 276, 39898-39902
37. Vaughan, A. M., Tang, C., and Oram, J. F. (2009) ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation. J. Lipid Res. 50, 285-292
38. Vedhachalam, C., Chetty, P. S., Nickel, M., Dhanasekaran, P., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (2010) Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution. J. Biol. Chem. 285, 31965-31973
39. Davies, G. E., and Stark, G. R. (1970) Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins. Proc. Natl. Acad. Sci. U. S. A. 66, 651-656
40. Swaney, J. B. (1986) Use of cross-linking reagents to study lipoprotein structure. Methods Enzymol. 128, 613-626
41. Sezgin, E., Kaiser, H.J., Baumgart, T., Schwille, P., Simons, K., and Levental, I. (2012) Elucidating membrane structure and protein behavior using giant plasma membrane vesicles. Nat. Protoc. 7, 1042-1051
42. Bellini, F., Phillips, M. C., Pickell, C., and Rothblat, G. H. (1984) Role of the plasma membrane in the mechanism of cholesterol efflux from cells. Biochim. Biophys. Acta 777, 209-215 (Pubitemid 15223882)
43. Rouser, G., Fleischer, S., and Yamamoto, A. (1970) Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5, 494-496
44. Klansek, J. J., Yancey, P., St Clair, R. W., Fischer, R. T., Johnson, W. J., and Glick, J. M. (1995) Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. J. Lipid Res. 36, 2261-2266
45. Zheng, P., Horwitz, A., Waelde, C. A., and Smith, J. D. (2001) Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL. Biochim. Biophys. Acta 1534, 121-128 (Pubitemid 34084968)
46. Costet, P., Lalanne, F., Gerbod-Giannone, M. C., Molina, J. R., Fu, X., Lund, E. G., Gudas, L. J., and Tall, A. R. (2003) Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol. Cell. Biol. 23, 7756-7766 (Pubitemid 37271473)
47. Vaughan, A. M., and Oram, J. F. (2006) ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J. Lipid Res. 47, 2433-2443 (Pubitemid 44936105)
48. Vaughan, A. M., and Oram, J. F. (2003) ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J. Lipid Res. 44, 1373-1380 (Pubitemid 37279619)
49. Singaraja, R. R., Brunham, L. R., Visscher, H., Kastelein, J. J., and Hayden, M. R. (2003) Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler. Thromb. Vasc. Biol. 23, 1322-1332 (Pubitemid 36994518)
50. Bhat, S., Sorci-Thomas, M. G., Alexander, E. T., Samuel, M. P., and Thomas, M. J. (2005) Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry. J. Biol. Chem. 280, 33015-33025 (Pubitemid 41368351)
51. Tian, S., and Jonas, A. (2002) Structural and functional properties of apolipoprotein A-I mutants containing disulfide-linked cysteines at positions 124 or 232. Biochim. Biophys. Acta 1599, 56-64 (Pubitemid 38234512)
52. Jonas, A., Kézdy, K. E., and Wald, J. H. (1989) Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264, 4818-4824 (Pubitemid 19092889)
53. Le Goff, W., Zheng, P., Brubaker, G., and Smith, J. D. (2006) Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements. Arterioscler. Thromb. Vasc. Biol. 26, 527-533
54. Lyssenko, N. N., Hata, M., Dhanasekaran, P., Nickel, M., Nguyen, D., Chetty, P. S., Saito, H., Lund-Katz, S., and Phillips, M. C. (2012) Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality. Biochim. Biophys. Acta 1821, 456-463
55. Sontag, T. J., Carnemolla, R., Vaisar, T., Reardon, C. A., and Getz, G. S. (2012) Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J. Lipid Res. 53, 951-963
56. Asztalos, B. F., Schaefer, E. J., Horvath, K. V., Yamashita, S., Miller, M., Franceschini, G., and Calabresi, L. (2007) Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J. Lipid Res. 48, 592-599 (Pubitemid 46397462)
57. Rubin, E. M., Ishida, B. Y., Clift, S. M., and Krauss, R. M. (1991) Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. U. S. A. 88, 434-438 (Pubitemid 21915479)
58. Alexander, E. T., Vedhachalam, C., Sankaranarayanan, S., de la Llera-Moya, M., Rothblat, G. H., Rader, D. J., and Phillips, M. C. (2011) Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice. Arterioscler. Thromb. Vasc. Biol. 31, 320-327
59. Graversen, J. H., Castro, G., Kandoussi, A., Nielsen, H., Christensen, E. I., Norden, A., and Moestrup, S. K. (2008) A pivotal role of the human kidney in catabolism of HDL protein components apolipoprotein A-I and A-IV but not of A-II. Lipids 43, 467-470
60. Tabas, I. (2002) Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905-911
61. Gu, F., Jones, M. K., Chen, J., Patterson, J. C., Catte, A., Jerome, W. G., Li, L., and Segrest, J. P. (2010) Structures of discoidal high density lipoproteins: a combined computational-experimental approach. J. Biol. Chem. 285, 4652-4665
62. Zorich, N. L., Kézdy, K. E., and Jonas, A. (1987) Properties of discoidal complexes of human apolipoprotein A-I with phosphatidylcholines containing various fatty acid chains. Biochim. Biophys. Acta 919, 181-189 (Pubitemid 17076679)
63. Massey, J. B., and Pownall, H. J. (2008) Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I. Biochim. Biophys. Acta 1781, 245-253
64. Tall, A. R., and Lange, Y. (1978) Interaction of cholesterol, phospholipid and apoprotein in high density lipoprotein recombinants. Biochim. Biophys. Acta 513, 185-197 (Pubitemid 9041382)
65. Asztalos, B. F., Brousseau, M. E., McNamara, J. R., Horvath, K. V., Roheim, P. S., and Schaefer, E. J. (2001) Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 156, 217-225 (Pubitemid 32429615)
66. Lin, G., and Oram, J. F. (2000) Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis 149, 359-370 (Pubitemid 30145546)
67. Gillotte, K. L., Davidson, W. S., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (1998) Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. J. Lipid Res. 39, 1918-1928 (Pubitemid 28462349)